327178-93-8

327178-93-8 structure
327178-93-8 structure

Name Sodium (2S,8R)-2-amino-5-hydroxy-11-oxo-8-[(2H27)tetradecanoyloxy](12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-2H27)-4,6,10-trioxa-5-phosphatetracosan-1-oate 5-oxide
Synonyms Sodium (2S,8R)-2-amino-5-hydroxy-11-oxo-8-[(H)tetradecanoyloxy](12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,21,21,22,22,23,23,24,24,24-H)-4,6,10-trioxa-5-phosphatetracosan-1-oa te 5-oxide
Tetradecanoic-d acid, (1R)-1-[[[[(2S)-2-amino-2-carboxyethoxy]hydroxyphosphinyl]oxy]methyl]-1,2-ethanediyl ester, sodium salt (1:1)
Description 1,2-Dimyristoyl-sn-glycero-3-phospho-L-serine-d54 (sodium) is deuterium labeled 1,2-Dimyristoyl-sn-glycero-3-phospho-L-serine.
Related Catalog
In Vitro Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[2].
References

[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

Molecular Formula C34H11D54NNaO10P
Molecular Weight 756.177
Exact Mass 755.763306